Close
Biotechgate
| |

Home Page

Action required: Please refresh your browser

We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.

More details about this topic are available here »

News in the Life Sciences Industry

Results 7381 - 500 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25
Reset 

Amarin Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

Read more ››
By: GlobeNewswire - 29 Feb 2024
Related companies:  Amarin Corporation plc

Vantage Hemp Co. Achieves GMP Certification from Australia's Therapeutic Goods Administration

Read more ››
By: GlobeNewswire - 29 Feb 2024

Coave Therapeutics Receives Grant from the ALS Association to Advance its CTx-TFEB Program as a Potential Treatment for All Forms of ALS

Read more ››
By: GlobeNewswire - 29 Feb 2024
Related companies:  Coave Therapeutics

EDAP Announces Record Preliminary Fourth Quarter and Full-Year 2023 Revenues

Read more ››
By: GlobeNewswire - 29 Feb 2024
Related companies:  EDAP TMS S.A.

Compass Pathways Announces Fourth Quarter 2023 Financial Results and Business Highlights 

Read more ››
By: GlobeNewswire - 29 Feb 2024
Related companies:  COMPASS Pathways plc

TELA Bio to Announce Fourth Quarter and Full Year 2023 Financial Results

Read more ››
By: GlobeNewswire - 29 Feb 2024
Related companies:  TELA Bio, Inc

ASLAN Pharmaceuticals Receives Favorable Opinion From the European Patent Office on Composition of Matter Patent Application for Farudodstat

Read more ››
By: GlobeNewswire - 29 Feb 2024
Related companies:  ASLAN Pharmaceuticals Ltd.

Emergent BioSolutions to Release Fourth Quarter & Full Year 2023 Financial Results, and Conduct Conference Call on March 6, 2024

Read more ››
By: GlobeNewswire - 29 Feb 2024
Related companies:  Emergent BioSolutions Inc. | Erste Group Bank AG

Milestone Pharmaceuticals Announces Pricing of $30.0 Million Public Offering of Common Shares and Pre-Funded Warrants

Read more ››
By: GlobeNewswire - 29 Feb 2024
Related companies:  Milestone Pharmaceuticals Inc.

Fennec Pharmaceuticals Reports Preliminary Unaudited Net Revenue for Fourth Quarter and Full-Year 2023 Results

Read more ››
By: GlobeNewswire - 29 Feb 2024
Related companies:  Fennec Pharmaceuticals Inc.

Clearside Biomedical to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Corporate Update on Tuesday, March 12, 2024

Read more ››
By: GlobeNewswire - 29 Feb 2024
Related companies:  Clearside Biomedical, Inc.

Arbutus Reports Fourth Quarter and Year End 2023 Financial Results and Provides Corporate Update

Read more ››
By: GlobeNewswire - 29 Feb 2024
Related companies:  Arbutus Biopharma Corporation

Progyny, Inc. Announces Share Repurchase Program

Read more ››
By: GlobeNewswire - 29 Feb 2024
Related companies:  Progyny, Inc.

Avicanna Hosts Symposium on Cannabinoid-based Medicine  

Read more ››
By: GlobeNewswire - 29 Feb 2024
Related companies:  Avicanna Inc.

Cytokinetics Joins Global Initiative to Recognize International Rare Disease Day

Read more ››
By: GlobeNewswire - 29 Feb 2024
Related companies:  Cytokinetics, Inc.

Verrica Pharmaceuticals Reports Fourth Quarter and Full-Year 2023 Financial Results

Read more ››
By: GlobeNewswire - 29 Feb 2024
Related companies:  Verrica Pharmaceuticals Inc.

Evaxion to Host R&D Day on March 19, 2024, Highlighting its Latest Technology Innovations

Read more ››
By: GlobeNewswire - 29 Feb 2024
Related companies:  Evaxion Biotech A/S

Vericel Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Full-Year 2024 Financial Guidance

Read more ››
By: GlobeNewswire - 29 Feb 2024
Related companies:  Vericel Corporation

ZyVersa Therapeutics Generated Approximately $2.7 Million From Exercise of Warrants Following Excitement Around News That Inflammasome Inhibitors Have Potential to Effectively Treat Obesity

Read more ››
By: GlobeNewswire - 29 Feb 2024
Related companies:  ZyVersa Therapeutics, Inc.

MoonLake Immunotherapeutics Reports Full Year 2023 Financial Results, Recent Business Highlights and Announces an R&D Day on March 10

Read more ››
By: GlobeNewswire - 29 Feb 2024
Related companies:  MoonLake Immunotherapeutics AG
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25
to the top ↑